MIM
CNTA

Monashee Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Monashee Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-161,293
Closed -$2.58M – 48
2024
Q3 		$2.58M Buy
161,293
+58,102
+56% +$712K 0.28% 52
2024
Q2 		$932K Buy
+103,191
New +$979K 0.12% 62
2021
Q3 		– Sell
-130,000
Closed -$2.89M – 293
2021
Q2 		$2.89M Buy
+130,000
New +$3.06M 0.35% 79

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Monashee Investment Management's CNTA Position: Q4 2024 in Review

Monashee Investment Management sold out of Centessa Pharmaceuticals (CNTA) in Q4 2024, closing a stake of 161,293 shares — an estimated $2.58M sold.

Monashee Investment Management first reported a position in CNTA in Q2 2021 and held it in 3 quarters. The position peaked at $2.89M in Q2 2021. 114 funds tracked by Wall St. Rank hold CNTA as of Q4 2024.

  • Monashee Investment Management reported no remaining Centessa Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Monashee Investment Management sold 161,293 Centessa Pharmaceuticals shares in Q4 2024, an estimated $2.58M.
  • Monashee Investment Management first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Monashee Investment Management's Centessa Pharmaceuticals position peaked at $2.89M in Q2 2021.
  • 114 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2024.

Based on Monashee Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.